GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $246,000 | -3.9% | 3,615 | -51.1% | 0.00% | 0.0% |
| Q1 2022 | $256,000 | +5.3% | 7,387 | -10.9% | 0.00% | 0.0% |
| Q4 2021 | $243,000 | -28.5% | 8,287 | +34.6% | 0.00% | -50.0% |
| Q3 2020 | $340,000 | -6.8% | 6,159 | +6.4% | 0.00% | -33.3% |
| Q2 2020 | $365,000 | +10.9% | 5,789 | -10.1% | 0.00% | 0.0% |
| Q1 2020 | $329,000 | -27.1% | 6,440 | +13.5% | 0.00% | 0.0% |
| Q4 2019 | $451,000 | +87.9% | 5,672 | +14.5% | 0.00% | +50.0% |
| Q3 2019 | $240,000 | -4.0% | 4,955 | +4.2% | 0.00% | 0.0% |
| Q2 2019 | $250,000 | -22.8% | 4,755 | -22.4% | 0.00% | -33.3% |
| Q1 2019 | $324,000 | +24.6% | 6,125 | -3.2% | 0.00% | 0.0% |
| Q4 2018 | $260,000 | 0.0% | 6,330 | -7.7% | 0.00% | +50.0% |
| Q3 2018 | $260,000 | +8.3% | 6,855 | +29.3% | 0.00% | -33.3% |
| Q2 2018 | $240,000 | – | 5,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |